Business
Changes to Board Structure & CFO Appointment
Changes to Board Structure & CFO Appointment.
About this update from Surgical Innovations Group Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 3120S\n Surgical Innovations Group PLC\n 15 November 2021\n \n \n \n \n Surgical Innovations Group plc\n \n \n (\"Surgical Innovations\", or the \"Group\n \")\n \n \n \n \n \n Planned changes to board structure and composition and appointment of Charmaine Day FCCA as Chief Financial Officer\n \n \n \n \n \n Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative technology for minimally invasive surgery, provides details of planned changes to board structure and composition, and the appointment of Charmaine Day as Chief Financial Officer (CFO).\n \n \n \n \n \n Charmaine is a Chartered Certified Accountant and has had responsibility for all financial aspects of the Group since July 2019, whilst also serving as Company Secretary since 2017. We are pleased to announce that she will join the board with immediate effect as CFO. Charmaine joined Surgical Innovations in 2012 as Financial Controller, beginning her career in finance for Eville & Jones Ltd and later as Management Accountant at Ellis Fairbank PLC. \n \n \n \n \n \n Additional regulatory disclosures relating to Charmaine's appointment to the Board are included below.\n \n \n \n \n \n The current directors have given careful consideration to the appropriate board structure to fulfill the future strategic and governance needs of the business. The outcome of this review concludes that the optimal structure is a board of five directors comprising three non-executive directors (including an independent chair and a senior independent director), and two executive directors, being the Chief Executive Officer (CEO) and the CFO. \n \n \n \n \n \n As part of a planned process to transition to this agreed structure, two of the current directors, Alistair Taylor and Adam Power, have indicated their intention to step down from the board with effect from 31 December 2021. Alistair joined the board in January 2016 as an Independent Non-executive Director, and Adam Power has been Business Development Director since the acquisition of Elemental Healthcare in August 2017. On 7 January 2021, it was announced that Adam would retire from his executive responsibilities at the end of the year, and he has now decided to also step down from the board. At that st...